INOTEK PHARMACEUTICALS CORP's ticker is and the CUSIP is 45780VAB8. A total of 9 filers reported holding INOTEK PHARMACEUTICALS CORP in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DeepCurrents Investment Group LLC | 17,300,000 | $10,553,000 | 0.90% |
| Bruce & Co., Inc. | 2,000,000 | $2,000,000 | 0.43% |
| TFG Asset Management GP Ltd | 2,800,000 | $2,895,000 | 0.42% |
| Verition Fund Management LLC | 7,300,000 | $7,389,000 | 0.21% |
| WOLVERINE ASSET MANAGEMENT LLC | 7,500,000 | $7,461,000 | 0.10% |
| Citadel Advisors | 14,750,000 | $14,791,000 | 0.01% |
| CREDIT SUISSE AG/ | 2,500,000 | $2,493,000 | 0.00% |
| DEUTSCHE BANK AG\ | 4,000,000 | $3,989,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |